Our Pricing

Wegovy Private Prescription UK: No NHS Waiting List Required

Published on: June 03, 2026

If you're searching for a wegovy private prescription uk no waiting list option, Cured Pharmacy offers immediate access to this clinically-proven weight loss treatment. Our UK-registered prescribers can assess your suitability in under 3 minutes, with Wegovy available from £79.00 and discreet next-day delivery across the UK.

Why Choose Private Wegovy Over NHS Waiting Lists

NHS waiting lists for weight loss prescriptions can extend for months, leaving many patients unable to access treatment when they need it most. Private prescriptions through registered UK pharmacies like Cured Pharmacy eliminate this delay entirely, with clinical assessments completed the same day you apply [1].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed, ensuring you receive genuine UK-licensed Wegovy pens manufactured to MHRA standards. Unlike NHS pathways that may require multiple GP appointments and referrals, our streamlined online consultation takes under 3 minutes and connects you directly with UK prescribers who specialise in weight management.

Private access doesn't mean compromising on clinical safety. Every patient completes a comprehensive medical assessment covering contraindications, current medications, and weight loss history before a prescriber determines suitability. This mirrors NHS protocols whilst removing the administrative delays that characterise public healthcare pathways.

How Wegovy Works: The Science Behind Semaglutide

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone called glucagon-like peptide-1. This medication works through three distinct mechanisms: it slows gastric emptying so you feel fuller for longer, reduces appetite signals in the brain, and improves insulin sensitivity to help regulate blood sugar levels [2].

In the landmark STEP 1 trial involving 1,961 adults with obesity, participants using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to just 2.4% in the placebo group [2]. Importantly, 86.4% of Wegovy users lost at least 5% of their body weight — the threshold associated with meaningful health improvements including reduced cardiovascular risk and improved glycaemic control [3].

The once-weekly injection schedule makes Wegovy considerably more convenient than daily alternatives. You'll start on a low 0.25mg dose and gradually increase over 16-20 weeks to the maintenance dose of 2.4mg, allowing your body to adapt and minimising common side effects like nausea.

What to Expect During Treatment

Most patients notice reduced appetite within the first week of treatment, though maximum weight loss typically occurs between months 3 and 6. Your UK prescriber will monitor your progress through follow-up consultations, adjusting your dose if needed based on tolerability and clinical response. It's essential to combine Wegovy with a reduced-calorie diet and increased physical activity, as the medication works synergistically with lifestyle changes rather than replacing them.

Wegovy Dosing Schedule and What's Included

Each Wegovy pen delivers a single pre-measured dose, eliminating the need for manual drawing or dose calculation. The standard titration schedule approved by the MHRA begins with 0.25mg weekly for 4 weeks, then 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, and finally the maintenance dose of 2.4mg weekly [1].

When you order through Cured Pharmacy, your prescription will specify the appropriate dose based on where you are in the titration schedule. First-time patients typically receive the 0.25mg starter dose, whilst those already established on treatment can continue with their current strength. Each pen is supplied in a pre-filled, single-use format with a hidden needle for maximum comfort and ease of use.

Your Wegovy delivery includes full NHS-standard patient information leaflets, detailed injection technique guides, and access to our clinical support team should you have questions during treatment. We also provide a sharps bin for safe disposal of used pens, ensuring you can manage treatment safely at home without additional pharmacy visits.

Wegovy Private Prescription UK: Pricing and Availability

At Cured Pharmacy, Wegovy is available from £79.00 per pen with completely transparent pricing shown before you begin your consultation. This represents our lowest price guarantee across the UK, with no hidden fees, membership charges, or subscription lock-ins that some providers impose.

Your total cost will depend on your prescribed dose and treatment duration. Most patients require one pen per week, meaning a month's supply typically consists of 4 pens. We offer flexible ordering options allowing you to purchase single months or multiple months in advance, with discreet packaging and next-day delivery as standard across England, Scotland, Wales, and Northern Ireland.

Unlike some online providers, we display our prices upfront rather than requiring you to complete lengthy consultations before discovering costs. This transparency reflects our commitment to ethical pharmacy practice and ensures you can make informed decisions about private treatment without pressure or surprise charges.

Payment and Delivery Options

We accept all major UK debit and credit cards with secure encrypted payment processing. Once your prescription is approved by a UK prescriber, your order is typically dispatched within 24 hours via Royal Mail Tracked 24 or DPD next-day courier, depending on your location. All packaging is completely plain with no external markings indicating contents, protecting your privacy throughout the delivery process.

Who Can Use Wegovy: Eligibility Criteria

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above if you have at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. Your UK prescriber will calculate your BMI during the online consultation and assess whether you meet these clinical criteria.

Certain medical conditions preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy. Pregnant or breastfeeding women cannot use Wegovy, and you should discontinue treatment at least 2 months before planned conception due to the medication's long half-life [4].

If you're currently taking other weight loss medications, insulin, or certain diabetes medications, your prescriber will need to review potential interactions. This doesn't automatically disqualify you from treatment, but may require dose adjustments or additional monitoring to ensure safety. Our clinical team considers your complete medical profile before approving any prescription.

Common Side Effects and How to Manage Them

The most frequently reported side effects with Wegovy are gastrointestinal: nausea affects approximately 44% of users, diarrhoea 30%, vomiting 24%, and constipation 24%, though these figures come from clinical trials and real-world rates may vary [2]. Most GI symptoms are mild to moderate, occur primarily during dose escalation, and diminish as your body adapts to treatment.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat foods that slow digestion further, and stay well-hydrated throughout the day. Taking your injection in the evening rather than morning may help you sleep through peak nausea periods. If symptoms persist beyond the first few weeks at a given dose, contact your prescriber — they may recommend staying at your current dose longer before increasing.

Rare but serious side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and hypoglycaemia if used alongside certain diabetes medications. Seek immediate medical attention if you experience severe persistent stomach pain, yellowing of skin or eyes, or signs of allergic reaction such as rash, swelling, or difficulty breathing [4]. Our clinical support team at Cured Pharmacy remains available throughout your treatment should you need guidance on managing any adverse effects.

When to Contact Your Prescriber

You should arrange a follow-up consultation if you experience side effects that don't improve after 2 weeks, if you're unable to tolerate dose increases, or if you haven't lost at least 5% of your starting weight after 3-4 months on the maintenance dose. Your prescriber may adjust your treatment plan, recommend additional lifestyle support, or consider whether Wegovy remains the most appropriate option for your weight management goals.

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and results may vary between individuals. Weight loss outcomes depend on adherence to prescribed treatment alongside reduced-calorie diet and increased physical activity.